الجمعية السعودية لطب وجراحة الصدر

266 posts

الجمعية السعودية لطب وجراحة الصدر banner
الجمعية السعودية لطب وجراحة الصدر

الجمعية السعودية لطب وجراحة الصدر

@SaudiThoracic

Official account of the Saudi Thoracic Society. Serving patients and the public in pulmonary medicine, sharing accurate health information, and STS activities

Riyadh, Kingdom of Saudi Arabia Katılım Ocak 2018
0 Takip Edilen1.4K Takipçiler
الجمعية السعودية لطب وجراحة الصدر
A new study by Liangle Yang and colleagues analyzed 472,615 participants from the UK Biobank. Over a median follow-up of 12.5 years, the findings suggest that glucosamine intake may be linked to a lower risk of idiopathic pulmonary fibrosis (IPF). The study is published in European Journal of Nutrition (2026): Yang, L., Xie, Y., Yao, Y., et al., “Relationship between habitual glucosamine use and risk of incident idiopathic pulmonary fibrosis with the modification effect of genetic susceptibility: a prospective cohort study.” doi.org/10.1007/s00394… #IdiopathicPulmonaryFibrosis #PulmonaryFibrosis #IPFResearch #RespiratoryHealth
الجمعية السعودية لطب وجراحة الصدر tweet media
English
0
1
1
316
الجمعية السعودية لطب وجراحة الصدر
New evidence shows that community-acquired pneumonia hospitalizations are linked to a substantial, sustained increase in the risk of developing new noncommunicable diseases over the course of 5 years after infection. Pulmonary diseases accounted for the largest excess burden an attributable risk increase of 7.2% and a number needed to harm (NNH) of 14. Cardiovascular and kidney diseases also contributed, with attributable risk increases of 5.7% and 3.3% (NNH 18 and 31, respectively). Researchers also found smaller increases for metabolic disease (1.0%), CNS disease (0.7%), and neoplastic disease (0.3%). Reference: Julio Ramirez , et al. Open Forum Infectious Diseases, Volume 13, Issue 3, March 2026, ofag126, doi.org/10.1093/ofid/o…
الجمعية السعودية لطب وجراحة الصدر tweet media
English
0
0
2
27.4K
الجمعية السعودية لطب وجراحة الصدر
New study (J.-P. Frat et al.) compared high-flow nasal cannula (HFNC) vs. standard oxygen in acute hypoxemic respiratory failure: Day‑28 mortality: 14.6% (HFNC) vs. 14.6% (standard) — difference −0.05 pp (95% CI −4.21 to 4.10; P=0.98). Intubation by day 28: 42.4% (HFNC) vs. 48.4% (standard) — difference −5.93 pp (95% CI −11.78 to −0.08). Conclusion: HFNC did not significantly reduce 28‑day mortality, though intubation rates were modestly lower. Reference: nejm.org/doi/full/10.10…
الجمعية السعودية لطب وجراحة الصدر tweet media
English
0
0
1
212
الجمعية السعودية لطب وجراحة الصدر
📊 Recent Study Alert: A new study has revealed important findings on bleeding risks associated with Apixaban vs. Rivaroxaban in patients with acute venous thromboembolism. 🔍 Key Findings: - In the study, a primary outcome event occurred in 44 of 1345 patients (3.3%) in the apixaban group compared to 96 of 1355 patients (7.1%) in the rivaroxaban group. - This equates to a relative risk of 0.46 (95% CI: 0.33 to 0.65; P<0.001). 💡 The results indicate that the risk of clinically relevant bleeding is significantly lower with apixaban compared to rivaroxaban during a 3-month treatment period. Reference: Lana A. Castellucci, et al. New England Journal of Medicine, 2026; 394:1051-1060 DOI: [10.1056/NEJMoa2510703](doi.org/10.1056/NEJMoa…) #Research #Cardiology #Thrombosis #Apixaban #Rivaroxaban #HealthInsights
الجمعية السعودية لطب وجراحة الصدر tweet media
English
0
0
1
295
الجمعية السعودية لطب وجراحة الصدر
🌟 A New Hope for IPF Patients! 🌟 New findings reveal that nerandomilast is associated with a numerically lower risk of death in patients with idiopathic pulmonary fibrosis (IPF). 🔍 Key Results: Hazard Ratio for Death: 9 mg dose: 0.95 18 mg dose: 0.66 This evidence brings optimism for better management of IPF. Let's continue to advocate for advancements in treatment! Reference: Oldham JM, Azuma A, Kreuter M, et al. Nerandomilast in idiopathic pulmonary fibrosis: data from the whole follow-up period of the FIBRONEER-IPF trial. Am J Respir Crit Care Med. Published online February 21, 1026. doi:10.1093/ajrccm/aamag058 #IPF #Nerandomilast #MedicalResearch #pulmonaryfibrosis
الجمعية السعودية لطب وجراحة الصدر tweet media
English
0
2
4
458
الجمعية السعودية لطب وجراحة الصدر
🫁 Advancing Therapeutic Options for COPD Key insights from Prof. Alberto Papi at the STS 2025 International Conference. #COPD #Pulmonology #RespiratoryMedicine #STS2025 #COPD #Pulmonology #RespiratoryMedicine #MedicalEducation #SaudiThoracicSociety #SaudiCOPDGroup #الانسداد_الرئوي_المزمن #طب_الجهاز_التنفسي #المؤتمرات_الطبية #التعليم_الطبي
English
0
0
5
398